Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials
This grant funds clinical trials focused on Alzheimer's disease.
About this program
The Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials grant supports research initiatives aimed at advancing the understanding and treatment of Alzheimer's disease through clinical trials. This grant is designed for research institutions and organizations that are engaged in innovative clinical research related to Alzheimer's. The funding will facilitate the development and execution of clinical trials that test new therapies and interventions for Alzheimer's patients, ultimately contributing to improved outcomes and quality of life for those affected by the disease.
Eligibility
Eligible applicants include research institutions and organizations involved in Alzheimer's disease clinical research.